Log In
BCIQ
Print this Print this
 

CNTX-6970

  Manage Alerts
Collapse Summary General Information
Company Centrexion Therapeutics Corp.
DescriptionSelective cytokine CC chemokine receptor 2 (CCR2; CD192) antagonist
Molecular Target CC chemokine receptor 2 (CCR2) (CD192)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat chronic inflammatory pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/30/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today